Literature DB >> 20432260

Drug therapy: sorafenib.

Richard S Finn1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20432260     DOI: 10.1002/hep.23676

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

1.  Sorafenib Induced Hand-Foot Skin Reaction at Low Dose.

Authors:  Vrutika H Shah; Bhagyashree B Supekar; Rajesh P Singh; Jayesh I Mukhi
Journal:  Indian Dermatol Online J       Date:  2020-09-19

Review 2.  Current and future treatments for hepatocellular carcinoma.

Authors:  Alexander Schlachterman; Willie W Craft; Eric Hilgenfeldt; Avir Mitra; Roniel Cabrera
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

Review 3.  Resistance to receptor tyrosine kinase inhibitors in solid tumors: can we improve the cancer fighting strategy by blocking autophagy?

Authors:  Sanja Aveic; Gian Paolo Tonini
Journal:  Cancer Cell Int       Date:  2016-08-02       Impact factor: 5.722

4.  Improved Survival in Hepatocellular Carcinoma Patients with Cardiac Arrhythmia by Amiodarone Treatment through Autophagy.

Authors:  Sheng-Teng Huang; Wei-Fan Hsu; Hung-Sen Huang; Jia-Hau Yen; Mei-Chen Lin; Cheng-Yuan Peng; Hung-Rong Yen
Journal:  Int J Mol Sci       Date:  2019-08-15       Impact factor: 5.923

5.  Sorafenib-asssociated hand-foot syndrome treated with topical calcipotriol.

Authors:  Serkan Demirkan; Özgür Gündüz; Tuba Devrim
Journal:  JAAD Case Rep       Date:  2017-07-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.